Corcept Therapeutics (CORT) EPS (2012 - 2026)
Corcept Therapeutics (CORT) EPS from Dec 31, 2012 to Mar 31, 2026. The TTM Corcept Therapeutics (CORT) EPS is $0.42. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Corcept Therapeutics (CORT) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -77.61% |
| 3 Years TTM | -32.55% |
| 5 Years TTM | -18.83% |
Annual EPS change of Corcept Therapeutics (CORT)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.30 | -132.34% |
| 2025 | $0.94 | -30.00% |
| 2024 | $1.34 | +30.88% |
| 2023 | $1.03 | +9.14% |
| 2022 | $0.94 | -11.44% |
| 2021 | $1.06 | +16.95% |
| 2020 | $0.91 | +10.45% |
| 2019 | $0.82 | +25.42% |
| 2018 | $0.66 | -41.76% |
| 2017 | $1.13 | +1458.49% |
| 2016 | $0.07 | -223.53% |
| 2015 | -$0.06 | -81.11% |
| 2014 | -$0.31 | -32.84% |
| 2013 | -$0.46 | +20.88% |
| 2012 | -$0.38 | -0.74% |
| 2011 | -$0.38 | +7.08% |
| 2010 | -$0.36 | N/A |
Comparison Corcept Therapeutics (CORT) five years EPS CAGR with competitors
Corcept Therapeutics (CORT) five years EPS CAGR is -8.23%.